Intravascular Access of COVID-19 Patient Under Personal Protective Equipment
NCT ID: NCT04366297
Last Updated: 2020-04-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
41 participants
INTERVENTIONAL
2020-01-12
2020-02-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intravascular Access in Suspected/Confirmed COVID-19 Patient
NCT04366947
Intraosseous Versus Intravenous Vascular Access During Cardiac Arrest
NCT01119807
Superior Venous Access, Midline vs Ultrasound IVs
NCT03440944
Evaluating the Role of the Guidewire in Peripheral Intravenous Access: A Randomized Controlled Trial of Ultrasound-Guided Catheter Survival
NCT06107361
Efficacy of Prehospital Tourniquet Models for Arterial Occlusion in Upper and Lower Limbs
NCT06725602
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard of Care (Intravenous Cannula)
obtaining intravascular access using a ready standard intravenous cannula
Intravenous access
obtaining intravascular access using a standard intravenous cannula
IO access using NIO® set
receive an IO line in the proximal tibia localization. IO lines are placed using an FDA-approved device called an NIO®.
Intraosseous access
obtaining intravascular access using a ready intravenous NIO needle set
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intravenous access
obtaining intravascular access using a standard intravenous cannula
Intraosseous access
obtaining intravascular access using a ready intravenous NIO needle set
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* consent voluntary participation in the study
* none experience in resuscitation with personal protective equipment
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Poznan University of Medical Sciences
OTHER
Medical University of Bialystok
OTHER
Wroclaw Medical University
OTHER
Lazarski University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Łukasz Szarpak
Assoc Prof PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jacek Smereka, PhD
Role: PRINCIPAL_INVESTIGATOR
Wroclaw Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lazarski Univeristy
Warsaw, , Poland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Smereka J, Szarpak L, Filipiak KJ, Jaguszewski M, Ladny JR. Which intravascular access should we use in patients with suspected/confirmed COVID-19? Resuscitation. 2020 Jun;151:8-9. doi: 10.1016/j.resuscitation.2020.04.014. Epub 2020 Apr 15. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IO_PPE_MS_1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.